Matches in Wikidata for { <http://www.wikidata.org/entity/Q66035061> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66035061 description "clinical trial" @default.
- Q66035061 description "ensayu clínicu" @default.
- Q66035061 description "klinisch onderzoek" @default.
- Q66035061 description "клінічне випробування" @default.
- Q66035061 name "A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis" @default.
- Q66035061 name "A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis" @default.
- Q66035061 type Item @default.
- Q66035061 label "A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis" @default.
- Q66035061 label "A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis" @default.
- Q66035061 prefLabel "A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis" @default.
- Q66035061 prefLabel "A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis" @default.
- Q66035061 P1050 Q66035061-F7267D23-277B-48E6-8CF6-532E2721FCBA @default.
- Q66035061 P1132 Q66035061-68A2A6E3-61D6-4CDA-9E13-909A9AB595A1 @default.
- Q66035061 P1476 Q66035061-9909CADF-FE73-403E-8BAE-85B753A198C8 @default.
- Q66035061 P2899 Q66035061-C065D550-30F3-46AC-9138-E8D2949B66B5 @default.
- Q66035061 P3098 Q66035061-EF12B08D-4938-4726-9AE9-343522C88BDD @default.
- Q66035061 P31 Q66035061-7E8A8E61-1DE3-4DDD-BEF5-DD21F70E5F3D @default.
- Q66035061 P4135 Q66035061-48B28AB1-6AF3-45A5-9FEC-5F06260E799D @default.
- Q66035061 P580 Q66035061-AA73C4D9-91B9-4E17-9DCF-B4EE0BF22B14 @default.
- Q66035061 P6099 Q66035061-0CB556D6-E371-4B14-9058-9B005BADF9D0 @default.
- Q66035061 P6099 Q66035061-49568875-4185-49C4-A25F-C077A7502C9E @default.
- Q66035061 P8363 Q66035061-CB43A5C4-2A8A-405F-A768-2A4218B77562 @default.
- Q66035061 P1050 Q170990 @default.
- Q66035061 P1132 "+237" @default.
- Q66035061 P1476 "A Randomized, Placebo-Controlled, Multicenter, Blinded Phase I/II Study of the Safety of Escalating Doses of Ocrelizumab (PRO70769) in Subjects With Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate" @default.
- Q66035061 P2899 "+18" @default.
- Q66035061 P3098 "NCT00077870" @default.
- Q66035061 P31 Q30612 @default.
- Q66035061 P4135 "+80" @default.
- Q66035061 P580 "2004-02-01T00:00:00Z" @default.
- Q66035061 P6099 Q42824440 @default.
- Q66035061 P6099 Q5452194 @default.
- Q66035061 P8363 Q78089383 @default.